[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global Liver Cirrhosis Therapeutics Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

March 2020 | 140 pages | ID: 2672A210BC48EN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for Liver Cirrhosis Therapeutics is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Roche
GlaxoSmithKline
Gilead Sciences
Bristol-Myers Squibb
Bristol-Myers Squibb
Johnson & Johnson
Gwo Xi Stem Cell Applied Technology
Merck

Major Types Covered
Alcoholic cirrhosis
Postnecrotic cirrhosis
Biliary cirrhosis
Cardiac cirrhosis

Major Applications Covered
Hospital
Clinic

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Liver Cirrhosis Therapeutics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Liver Cirrhosis Therapeutics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE LIVER CIRRHOSIS THERAPEUTICS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL LIVER CIRRHOSIS THERAPEUTICS MARKET-SEGMENTATION BY TYPE

5.1 Alcoholic cirrhosis
5.2 Postnecrotic cirrhosis
5.3 Biliary cirrhosis
5.4 Cardiac cirrhosis

6 GLOBAL LIVER CIRRHOSIS THERAPEUTICS MARKET-SEGMENTATION BY APPLICATION

6.1 Hospital
6.2 Clinic

7 GLOBAL LIVER CIRRHOSIS THERAPEUTICS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Roche
  8.1.1 Roche Profile
  8.1.2 Roche Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Roche Product/Solution Launches and Enhancements Analysis
  8.1.4 Roche Business Overview/Recent Development/Acquisitions
8.2 GlaxoSmithKline
  8.2.1 GlaxoSmithKline Profile
  8.2.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
  8.2.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
8.3 Gilead Sciences
  8.3.1 Gilead Sciences Profile
  8.3.2 Gilead Sciences Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Gilead Sciences Product/Solution Launches and Enhancements Analysis
  8.3.4 Gilead Sciences Business Overview/Recent Development/Acquisitions
8.4 Bristol-Myers Squibb
  8.4.1 Bristol-Myers Squibb Profile
  8.4.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
  8.4.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.5 Bristol-Myers Squibb
  8.5.1 Bristol-Myers Squibb Profile
  8.5.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
  8.5.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.6 Johnson & Johnson
  8.6.1 Johnson & Johnson Profile
  8.6.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.6.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.7 Gwo Xi Stem Cell Applied Technology
  8.7.1 Gwo Xi Stem Cell Applied Technology Profile
  8.7.2 Gwo Xi Stem Cell Applied Technology Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Gwo Xi Stem Cell Applied Technology Product/Solution Launches and Enhancements Analysis
  8.7.4 Gwo Xi Stem Cell Applied Technology Business Overview/Recent Development/Acquisitions
8.8 Merck
  8.8.1 Merck Profile
  8.8.2 Merck Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Merck Product/Solution Launches and Enhancements Analysis
  8.8.4 Merck Business Overview/Recent Development/Acquisitions

9 GLOBAL LIVER CIRRHOSIS THERAPEUTICS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Liver Cirrhosis Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Liver Cirrhosis Therapeutics Production Analysis from 2015-2020
10.4 North America Liver Cirrhosis Therapeutics Consumption Analysis from 2015-2020
10.5 North America Liver Cirrhosis Therapeutics Import and Export from 2015-2020
10.6 North America Liver Cirrhosis Therapeutics Value, Production and Market Share by Type (2015-2020)
10.7 North America Liver Cirrhosis Therapeutics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Liver Cirrhosis Therapeutics by Country (United States, Canada)
  10.8.1 North America Liver Cirrhosis Therapeutics Sales by Country (2015-2020)
  10.8.2 North America Liver Cirrhosis Therapeutics Consumption Value by Country (2015-2020)
10.9 North America Liver Cirrhosis Therapeutics Market PEST Analysis

11 EUROPE

11.1 Europe Liver Cirrhosis Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Liver Cirrhosis Therapeutics Production Analysis from 2015-2020
11.4 Europe Liver Cirrhosis Therapeutics Consumption Analysis from 2015-2020
11.5 Europe Liver Cirrhosis Therapeutics Import and Export from 2015-2020
11.6 Europe Liver Cirrhosis Therapeutics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Liver Cirrhosis Therapeutics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Liver Cirrhosis Therapeutics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Liver Cirrhosis Therapeutics Sales by Country (2015-2020)
  11.8.2 Europe Liver Cirrhosis Therapeutics Consumption Value by Country (2015-2020)
11.9 Europe Liver Cirrhosis Therapeutics Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Liver Cirrhosis Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Liver Cirrhosis Therapeutics Production Analysis from 2015-2020
12.4 Asia-Pacific Liver Cirrhosis Therapeutics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Liver Cirrhosis Therapeutics Import and Export from 2015-2020
12.6 Asia-Pacific Liver Cirrhosis Therapeutics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Liver Cirrhosis Therapeutics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Liver Cirrhosis Therapeutics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Liver Cirrhosis Therapeutics Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Liver Cirrhosis Therapeutics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Liver Cirrhosis Therapeutics Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Liver Cirrhosis Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Liver Cirrhosis Therapeutics Production Analysis from 2015-2020
13.4 Latin America Liver Cirrhosis Therapeutics Consumption Analysis from 2015-2020
13.5 Latin America Liver Cirrhosis Therapeutics Import and Export from 2015-2020
13.6 Latin America Liver Cirrhosis Therapeutics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Liver Cirrhosis Therapeutics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Liver Cirrhosis Therapeutics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Liver Cirrhosis Therapeutics Sales by Country (2015-2020)
  13.8.2 Latin America Liver Cirrhosis Therapeutics Consumption Value by Country (2015-2020)
13.9 Latin America Liver Cirrhosis Therapeutics Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Liver Cirrhosis Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Liver Cirrhosis Therapeutics Production Analysis from 2015-2020
14.4 Middle East & Africa Liver Cirrhosis Therapeutics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Liver Cirrhosis Therapeutics Import and Export from 2015-2020
14.6 Middle East & Africa Liver Cirrhosis Therapeutics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Liver Cirrhosis Therapeutics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Liver Cirrhosis Therapeutics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Liver Cirrhosis Therapeutics Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Liver Cirrhosis Therapeutics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Liver Cirrhosis Therapeutics Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL LIVER CIRRHOSIS THERAPEUTICS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Liver Cirrhosis Therapeutics Market from 2020-2027 Segment by Region
15.2 Global Liver Cirrhosis Therapeutics Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Liver Cirrhosis Therapeutics Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

LIST OF TABLES AND FIGURES

Global Liver Cirrhosis Therapeutics Market Value ($) and Growth Rate of Liver Cirrhosis Therapeutics from 2015-2027
Global Liver Cirrhosis Therapeutics Production and Growth Rate Segment by Product Type from 2015-2027
Global Liver Cirrhosis Therapeutics Consumption and Growth Rate Segment by Application from 2015-2027
Figure Liver Cirrhosis Therapeutics Picture
Table Product Specifications of Liver Cirrhosis Therapeutics
Table Driving Factors for this Market
Table Industry News of Liver Cirrhosis Therapeutics Market
Figure Value Chain Status of Liver Cirrhosis Therapeutics
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Liver Cirrhosis Therapeutics Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Liver Cirrhosis Therapeutics Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Alcoholic cirrhosis of Liver Cirrhosis Therapeutics
Figure Postnecrotic cirrhosis of Liver Cirrhosis Therapeutics
Figure Biliary cirrhosis of Liver Cirrhosis Therapeutics
Figure Cardiac cirrhosis of Liver Cirrhosis Therapeutics
Table Global Liver Cirrhosis Therapeutics Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Liver Cirrhosis Therapeutics Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospital of Liver Cirrhosis Therapeutics
Figure Clinic of Liver Cirrhosis Therapeutics
Table Global Liver Cirrhosis Therapeutics Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Liver Cirrhosis Therapeutics Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Liver Cirrhosis Therapeutics
Figure Online Channel of Liver Cirrhosis Therapeutics
Table Roche Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Sales and Growth Rate from 2015-2020
Figure Roche Revenue ($) and Global Market Share from 2015-2020
Table Roche Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Gilead Sciences Profile (Company Name, Plants Distribution, Sales Region)
Figure Gilead Sciences Sales and Growth Rate from 2015-2020
Figure Gilead Sciences Revenue ($) and Global Market Share from 2015-2020
Table Gilead Sciences Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Gwo Xi Stem Cell Applied Technology Profile (Company Name, Plants Distribution, Sales Region)
Figure Gwo Xi Stem Cell Applied Technology Sales and Growth Rate from 2015-2020
Figure Gwo Xi Stem Cell Applied Technology Revenue ($) and Global Market Share from 2015-2020
Table Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Merck Profile (Company Name, Plants Distribution, Sales Region)
Figure Merck Sales and Growth Rate from 2015-2020
Figure Merck Revenue ($) and Global Market Share from 2015-2020
Table Merck Liver Cirrhosis Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Liver Cirrhosis Therapeutics Production Value ($) by Region from 2015-2020
Table Global Liver Cirrhosis Therapeutics Production Value Share by Region from 2015-2020
Table Global Liver Cirrhosis Therapeutics Production by Region from 2015-2020
Table Global Liver Cirrhosis Therapeutics Consumption Value ($) by Region from 2015-2020
Table Global Liver Cirrhosis Therapeutics Consumption by Region from 2015-2020
Table North America Liver Cirrhosis Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Liver Cirrhosis Therapeutics Import and Export from 2015-2020
Table North America Liver Cirrhosis Therapeutics Value ($) by Type (2015-2020)
Table North America Liver Cirrhosis Therapeutics Production by Type (2015-2020)
Table North America Liver Cirrhosis Therapeutics Consumption by Application (2015-2020)
Table North America Liver Cirrhosis Therapeutics Consumption by Country (2015-2020)
Table North America Liver Cirrhosis Therapeutics Consumption Value ($) by Country (2015-2020)
Figure North America Liver Cirrhosis Therapeutics Market PEST Analysis
Table Europe Liver Cirrhosis Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Liver Cirrhosis Therapeutics Import and Export from 2015-2020
Table Europe Liver Cirrhosis Therapeutics Value ($) by Type (2015-2020)
Table Europe Liver Cirrhosis Therapeutics Production by Type (2015-2020)
Table Europe Liver Cirrhosis Therapeutics Consumption by Application (2015-2020)
Table Europe Liver Cirrhosis Therapeutics Consumption by Country (2015-2020)
Table Europe Liver Cirrhosis Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Europe Liver Cirrhosis Therapeutics Market PEST Analysis
Table Asia-Pacific Liver Cirrhosis Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Liver Cirrhosis Therapeutics Import and Export from 2015-2020
Table Asia-Pacific Liver Cirrhosis Therapeutics Value ($) by Type (2015-2020)
Table Asia-Pacific Liver Cirrhosis Therapeutics Production by Type (2015-2020)
Table Asia-Pacific Liver Cirrhosis Therapeutics Consumption by Application (2015-2020)
Table Asia-Pacific Liver Cirrhosis Therapeutics Consumption by Country (2015-2020)
Table Asia-Pacific Liver Cirrhosis Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Liver Cirrhosis Therapeutics Market PEST Analysis
Table Latin America Liver Cirrhosis Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Liver Cirrhosis Therapeutics Import and Export from 2015-2020
Table Latin America Liver Cirrhosis Therapeutics Value ($) by Type (2015-2020)
Table Latin America Liver Cirrhosis Therapeutics Production by Type (2015-2020)
Table Latin America Liver Cirrhosis Therapeutics Consumption by Application (2015-2020)
Table Latin America Liver Cirrhosis Therapeutics Consumption by Country (2015-2020)
Table Latin America Liver Cirrhosis Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Latin America Liver Cirrhosis Therapeutics Market PEST Analysis
Table Middle East & Africa Liver Cirrhosis Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Liver Cirrhosis Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Liver Cirrhosis Therapeutics Import and Export from 2015-2020
Table Middle East & Africa Liver Cirrhosis Therapeutics Value ($) by Type (2015-2020)
Table Middle East & Africa Liver Cirrhosis Therapeutics Production by Type (2015-2020)
Table Middle East & Africa Liver Cirrhosis Therapeutics Consumption by Application (2015-2020)
Table Middle East & Africa Liver Cirrhosis Therapeutics Consumption by Country (2015-2020)
Table Middle East & Africa Liver Cirrhosis Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Liver Cirrhosis Therapeutics Market PEST Analysis
Table Global Liver Cirrhosis Therapeutics Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Liver Cirrhosis Therapeutics Production and Growth Rate Forecast by Region (2020-2027)
Table Global Liver Cirrhosis Therapeutics Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Liver Cirrhosis Therapeutics Production and Growth Rate Forecast by Type (2020-2027)
Table Global Liver Cirrhosis Therapeutics Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications